Dr. Benjamin Mark Frishberg, MD

Dr. Frishberg practices at Premier Pharmacy Services in Carlsbad, California.

Dr. Frishberg's NPI, 1952346348, was assigned on June 18, 2006. Dr. Frishberg graduated from University Of Minnesota Medical School in 1979. Dr. Frishberg holds California license G43493.

Dr. Frishberg's primary practice is Premier Pharmacy Services, at 6010 Hidden Valley Rd, Carlsbad, CA 92011 in San Diego County. The practice phone is (310) 869-2259.

Dr. Frishberg's primary practice is Premier Pharmacy Services in Carlsbad, California. Dr. Frishberg is also affiliated with Sharp Tri-City Medical Center. The medical group on file is The Neurology Center of Southern California. Dmand AI also links Dr. Frishberg to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Frishberg practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Frishberg's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Frishberg is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Frishberg's licenses on file in 4 states: California, District of Columbia, Maryland and Georgia.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, epilepsy, essential tremor, fibromyalgia and chronic pain, head injury and lower back pain among the conditions Dr. Frishberg treats.

CMS data shows 34,320 Medicare services from Dr. Frishberg across 12 procedure codes in 2024, for 451 Medicare patients. Medicare paid $238,571 for them. Every service was in an office.

CMS counts 451 Medicare patients who saw Dr. Frishberg in 2024. The largest group is 65 to 74, with 196 patients. 68% of them have high cholesterol, and 62% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Frishberg's median patient age at 62, with 66% women.

In 2024, Dr. Frishberg wrote 553 Medicare Part D claims for 106 patients. 71% of them were for generic drugs. CMS names the drug for 390 of them, across 19 drugs with 11 or more claims each, at $363,004 in total drug cost. In 2023, CMS named 445 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Frishberg for performance year 2024, reported as part of a group. Dr. Frishberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Frishberg as offering telehealth.

Dmand AI links 14 papers to Dr. Frishberg, published from 2010 to 2021. 2013 was the busiest year, with 2. The most frequent topics are Carotid Artery, Internal, Dissection, Headache and Migraine Disorders. Dr. Frishberg has published most often in Headache. Dr. Frishberg's most frequent co-authors are Stephen D. Silberstein, MD, Deborah I. Friedman, MD and Elizabeth W. Loder, MD.

Dmand AI links Dr. Frishberg to 7 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Cognitive Dysfunction, Alzheimer Disease and Delirium. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Frishberg that name 4 trials.

CMS Open Payments shows 4,024 general payments to Dr. Frishberg from 76 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 75% of the total. Sanofi and Genzyme US Companies paid the most, $325,885. It also lists 18 research payments totaling $34,235 from 2016 to 2024, naming 4 clinical trials.

Dmand AI lists 14 awards for Dr. Frishberg, most recently Best Doctors in 2023.

Dr. Frishberg graduated from University Of Minnesota Medical School in 1979. Dr. Frishberg is a member of AAN.

Dr. Frishberg is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.